Metabolic and hormonal side effects of mitotane treatment for adrenocortical carcinoma: A retrospective study in 50 Danish patients
Sign Up to like & getrecommendations! Published in 2020 at "Clinical Endocrinology"
DOI: 10.1111/cen.14345
Abstract: Mitotane is used in the treatment of adrenocortical carcinoma (ACC). Metabolic and hormonal side effects of mitotane, the effect of subsequent treatment with statins and hormones and the effects of discontinuation of mitotane were assessed. read more here.
Keywords: adrenocortical carcinoma; side effects; treatment; metabolic hormonal ... See more keywords